| Stage | ULS | % of rev | ESAB | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $816M | 100.00% | $808M | 100.00% | ULS ×1.01 |
| Gross profit | $417M | 51.10% | $307M | 38.04% | ULS +13.1pp |
| Operating income | $150M | 18.38% | $79M | 9.75% | ULS +8.6pp |
| Pre-tax income | $338M | 41.42% | $48M | 5.96% | ULS +35.5pp |
| Net income | $254M | 31.13% | $34M | 4.21% | ULS +26.9pp |
| Stage | ULS | ESAB | Gap · A − B |
|---|---|---|---|
| Revenue | $816M100.00% | $808M100.00% | ULS ×1.01 |
| Gross profit | 51.10%$417M | 38.04%$307M | ULS +13.1pp |
| Operating income | 18.38%$150M | 9.75%$79M | ULS +8.6pp |
| Pre-tax income | 41.42%$338M | 5.96%$48M | ULS +35.5pp |
| Net income |
| 31.13%$254M |
| 4.21%$34M |
| ULS +26.9pp |
No shared counterparties.